Wharton Equity Partners

Wharton Equity Partners is a diversified investment firm with a significant focus on real estate and venture capital. Founded in 1992, the firm operates through various platforms, including Wharton Strategic Capital, which targets high-growth sectors such as life sciences and technology. While the firm is primarily known for its extensive real estate portfolio in the industrial and residential sectors, it has a history of investing in biotechnology companies like Tyme Technologies and BioSig Technologies. Headquartered in New York and Miami, the firm provides strategic capital and operational expertise to its portfolio companies. It does not engage in direct drug development or clinical research but acts as a financial catalyst in the healthcare space.